Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Konrad Beyreuther awarded with the first Hartwig Piepenbrock-DZNE Prize

02.09.2011
The first "Hartwig Piepenbrock-DZNE Prize" for outstanding research in the field of neurodegenerative diseases will be awarded to the renowned Alzheimer researcher Prof. Konrad Beyreuther, Heidelberg University.

The award honors Beyreuther for the discovery of the nature of the amyloid protein, the key component of plaques found in brains of individuals suffering from Alzheimer's disease. The prize, endowed with 60,000 Euros, is donated by the Piepenbrock Group and recognizes outstanding scientific contributions towards the understanding, prevention and cure of neurodegenerative disorders such as Alzheimer's and Parkinson's diseases. The award is decided by an international scientific committee coordinated by the German Centre for Neurodegenerative Diseases (DZNE).

The award ceremony will take place at the scientific conference on "Ageing and Neurodegeneration" (Schloss Bensberg, Bergisch Gladbach). The guests will be welcomed by Olaf Piepenbrock, CEO and Chairman of Piepenbrock Group. Prof. Pierluigi Nicotera, Scientific Director of the DZNE, will give a tribute speech, the prize will be awarded by benefactress Maria-Theresia Piepenbrock.

Background
A key feature of Alzheimer's disease is the formation of protein deposits in the brains of patients associated with progressive neuronal cell damage and eventually cell death. In the 1980’s – almost 80 years after the German physician Alois Alzheimer discovered these so called "Alzheimer plaques" – Konrad Beyreuther successfully identified their biochemical composition. This groundbreaking discovery marked the beginning of the molecular study of Alzheimer's disease, a hitherto entirely obscure disorder. In the decades to follow, Beyreuther has continued his work to elucidate the causes of Alzheimer's disease. He and his colleagues were able to identify how the protein deposits arise and how this process could be inhibited in laboratory models. There is as yet no cure for Alzheimer's disease. But there is well-founded hope that recent research progress will lead to the development of effective new therapies within the next 10-15 years – and to this, Beyreuther has contributed significantly.
The awardee
Konrad Beyreuther received his Ph.D. in 1968 at the Max Planck Institute for Biochemistry in Munich. From 1968 to 1987 he performed his research work at the Institute of Genetics at the Albertus Magnus University of Cologne, and became professor in 1980. From 1987 to 2007 Beyreuther was professor at the Zentrum für Molekulare Biologie der Universität Heidelberg (ZMBH) and since 2006 he has led the Network Aging Research at the Heidelberg University. Beyreuther has received several awards for his research on the molecular understanding of Alzheimer's disease. In addition, he served as a member of the Baden-Wuerttemberg state government in the role of State Councillor for the Protection of Life and Health, from 2001 to 2006.
About Piepenbrock
The Piepenbrock Group is an owner-managed family business, now in its fourth generation. Piepenbrock provides its clients with a broad range of services, e.g. in the areas of facility management, cleaning services, maintenance and security services. With its affiliated companies LoeschPack and Hastamat, Piepenbrock successfully produces packaging machines. The Piepenbrock Group has a long tradition of promoting sports, environmental protection and arts. Piepenbrock now adds support of neurodegenerative disease research to its social commitments, in recognition of the profound impact these disorders impose on patients, families and carers.
About DZNE
The DZNE was established as a research center in the Helmholtz Association in 2009 with the goals of investigating the underlying causes of neurodegenerative diseases and developing new interventions and health care strategies to combat them. Research activities within the DZNE network of nine sites cover the entire scientific spectrum, from the investigation of molecular processes in neurons, to clinical and population-based sciences and to health care systems research.

Katrin Weigmann | idw
Further information:
http://www.dzne.de/
http://www.zmbh.uni-heidelberg.de/Beyreuther/

More articles from Awards Funding:

nachricht Helmholtz International Fellow Award for Sarah Amalia Teichmann
20.01.2017 | Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt

nachricht Scientist from Kiel University coordinates Million Euros Project in Inflammation Research
19.01.2017 | Christian-Albrechts-Universität zu Kiel

All articles from Awards Funding >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Traffic jam in empty space

New success for Konstanz physicists in studying the quantum vacuum

An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...

Im Focus: How gut bacteria can make us ill

HZI researchers decipher infection mechanisms of Yersinia and immune responses of the host

Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...

Im Focus: Interfacial Superconductivity: Magnetic and superconducting order revealed simultaneously

Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.

While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...

Im Focus: Studying fundamental particles in materials

Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales

Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...

Im Focus: Designing Architecture with Solar Building Envelopes

Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.

As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Sustainable Water use in Agriculture in Eastern Europe and Central Asia

19.01.2017 | Event News

12V, 48V, high-voltage – trends in E/E automotive architecture

10.01.2017 | Event News

2nd Conference on Non-Textual Information on 10 and 11 May 2017 in Hannover

09.01.2017 | Event News

 
Latest News

Helmholtz International Fellow Award for Sarah Amalia Teichmann

20.01.2017 | Awards Funding

An innovative high-performance material: biofibers made from green lacewing silk

20.01.2017 | Materials Sciences

Ion treatments for cardiac arrhythmia — Non-invasive alternative to catheter-based surgery

20.01.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>